The Memory Alteration Test Discriminates between Cognitively Healthy Status Mild Cognitive Impairment and Alzheimers Disease

摘要

Background/AimsDementia is a worldwide public health problem and there are several diagnostic tools for its assessment. The aim of this study was to evaluate the performance of the Memory Alteration Test (M@T) to discriminate between patients with early Alzheimer's disease (AD), patients with amnestic mild cognitive impairment (a-MCI), and subjects with a cognitively healthy status (CHS).